Quadrature Capital’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Quadrature Capital’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,625	Closed	-$245K	–	1649
2025 Q4	$245K	Buy	+11,625	New	+$315K	﹤0.01%	912
2025 Q2	–	Sell	-11,032	Closed	-$1.04M	–	1293
2025 Q1	$1.04M	Buy	+11,032	New	+$807K	0.02%	421
2024 Q3	–	Sell	-3,446	Closed	-$253K	–	1189
2024 Q2	$253K	Buy	+3,446	New	+$291K	﹤0.01%	874

Other funds holding LABD

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

CCM

Capstone Capital Management Hong Kong $224M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Quadrature Capital's LABD Position: Q1 2026 in Review

Quadrature Capital sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2026, closing a stake of 11,625 shares — an estimated $245K sold.

Quadrature Capital first reported a position in LABD in Q2 2024 and held it in 3 quarters. The position peaked at $1.04M in Q1 2025. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

Quadrature Capital reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2026 after selling out during the quarter.
Quadrature Capital sold 11,625 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $245K.
Quadrature Capital first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2024 and held it in 3 quarters.
Quadrature Capital's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.04M in Q1 2025.
17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.